Investigation of Impact of AI on Prostate Cancer Workflow

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

July 17, 2025

Primary Completion Date

March 30, 2026

Study Completion Date

March 30, 2026

Conditions
Prostate CancerProstatic NeoplasmCancer of the ProstateNeoplasms, Prostate
Interventions
DEVICE

AI

"Following the completion of a pre-biopsy prostate MRI, the radiologist will interpret the MRI. Once interpreted by the radiologist alone, the radiologist will interpret the scan while aided by AI. A systematic biopsy in conjunction with radiologist-identified targets will be completed per standard of care, with the optional inclusion of up to 2 AI-detected targets.~When completing a biopsy per SOC, the prostate is divided into quadrants. In addition to noted targets, samples are taken systematically from each quadrant. If targets are detected by AI that were not identified by the physician when reviewing the MRI, these targets will be sampled. Sampling of these targets will not be in addition to the systematic sampling in each quadrant, but in place of up to two of the samples biopsied systematically"

Trial Locations (1)

44195

RECRUITING

Cleveland Clinic Foundation, Cleveland

All Listed Sponsors
collaborator

Siemens Medical Solutions

INDUSTRY

lead

Case Comprehensive Cancer Center

OTHER

NCT07084779 - Investigation of Impact of AI on Prostate Cancer Workflow | Biotech Hunter | Biotech Hunter